FDA – Page 71 – Pharma.Tips

CSV not aligned to actual use during validation lifecycle – CAPA and revalidation strategy

Investigation of CSV Misalignment during the Validation Lifecycle in Pharma Operations In the complex environment of pharmaceutical manufacturing and quality assurance, compliance with Good Manufacturing Practices (GMP) is paramount. A…

Transport qualification gaps during audit – regulatory inspection outcome

Understanding and Addressing Transport Qualification Gaps During Audit Outcomes Transport qualification is a critical component of ensuring that pharmaceutical products remain compliant with Good Manufacturing Practices (GMP) throughout the supply…

CSV not aligned to actual use during system upgrades – preventing repeat CSV observations

Understanding the Impact of Inconsistent CSV During System Upgrades in Pharmaceutical Operations In the highly regulated pharmaceutical industry, the alignment of Computer System Validation (CSV) with actual operational use is…

Supplier change unqualified during storage – how to prevent repeat excursions

Managing Unqualified Supplier Changes During Storage to Prevent Future Excursions In pharmaceutical manufacturing, maintaining the integrity of products throughout the supply chain is paramount. When there is a supplier change…

System access control failure during validation lifecycle – FDA/EMA expectations for computerized systems

Evaluating System Access Control Failures During the Validation Lifecycle In today’s highly regulated pharmaceutical environment, the integrity and security of computerized systems are paramount. A system access control failure can…

Supplier change unqualified during storage – product quality risk assessment

Assessing Product Quality Risks Due to Unqualified Supplier Changes During Storage In today’s complex pharmaceutical landscape, managing supplier qualifications effectively is critical for ensuring product integrity. However, scenarios may arise…

System access control failure during inspection walkthrough – FDA/EMA expectations for computerized systems

Addressing System Access Control Failures During Inspection Walkthroughs: An Investigation Approach Pharmaceutical manufacturers often encounter system access control failures during regulatory inspections, which can impact compliance with Good Manufacturing Practices…

Excursion trend ignored during inspection – CAPA and system remediation

Investigating Ignored Excursion Trends During Inspections In the world of pharmaceutical manufacturing, oversight of critical excursions can lead to significant compliance issues that affect product quality and patient safety. Recent…

Audit trail gaps identified during system upgrades – inspection evidence pack preparation

Identifying Audit Trail Gaps During System Upgrades: A Comprehensive Investigation Guide Audit trails are critical in ensuring data integrity within pharmaceutical operations, serving as a backbone for compliance with regulatory…

Audit trail gaps identified during system upgrades – inspection evidence pack preparation

Addressing Audit Trail Gaps Identified During System Upgrades Audit trail gaps are critical issues in the pharmaceutical manufacturing environment, particularly during system upgrades. Such gaps can lead to non-compliance with…

Transport qualification gaps during storage – how to prevent repeat excursions

Addressing Transport Qualification Gaps During Storage to Prevent Future Excursions Transport qualification gaps can lead to significant challenges in pharmaceutical manufacturing. For companies operating in regulated environments, understanding and addressing…

User account governance failures during system operation – CAPA and revalidation strategy

User Account Governance Failures During System Operation: Investigation and Remediation Strategies User account governance is a critical component of regulated pharmaceutical environments, particularly where system access and data integrity are…